Natarajan Sethuraman Entrada Therapeutics, Inc. (TRDA) insider trading activity

Natarajan Sethuraman is President, Research & Develop. of Entrada Therapeutics, Inc.. Currently has a direct ownership of 144,997 shares of TRDA, which is worth approximately $2.53 Million. The most recent transaction as insider was on Dec 03, 2024, when has been sold 11,703 shares (Common Stock) at a price of $20.15 per share, resulting in proceeds of $235,815. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K

21.12% 3M change

13.28% 12M change

Total Value Held $2.53 Million

Natarajan Sethuraman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2024	SELL Open market or private sale	$235,815 $20.15 p/Share	11,703 Reduced 7.47%	144,997 Common Stock
Dec 02 2024	SELL Open market or private sale	$82,822 $20.26 p/Share	4,088 Reduced 2.54%	156,700 Common Stock
Nov 29 2024	SELL Open market or private sale	$2,000 $20.0 p/Share	100 Reduced 0.06%	160,788 Common Stock
Nov 13 2024	SELL Open market or private sale	$54,108 $20.04 p/Share	2,700 Reduced 1.65%	160,888 Common Stock
Nov 11 2024	SELL Open market or private sale	$28,194 $20.01 p/Share	1,409 Reduced 0.85%	163,588 Common Stock
Nov 06 2024	SELL Open market or private sale	$233,803 $19.01 p/Share	12,299 Reduced 6.94%	164,997 Common Stock
Nov 05 2024	SELL Open market or private sale	$94,008 $18.18 p/Share	5,171 Reduced 2.83%	177,296 Common Stock
Nov 04 2024	SELL Open market or private sale	$13,496 $18.02 p/Share	749 Reduced 0.41%	182,467 Common Stock
Oct 16 2024	SELL Open market or private sale	$10,800 $18.0 p/Share	600 Reduced 0.33%	183,216 Common Stock
Sep 09 2024	SELL Open market or private sale	$39,867 $15.09 p/Share	2,642 Reduced 1.42%	183,816 Common Stock
Sep 06 2024	SELL Open market or private sale	$9,144 $15.24 p/Share	600 Reduced 0.32%	186,458 Common Stock
Sep 05 2024	SELL Payment of exercise price or tax liability	$2,526 $15.13 p/Share	167 Reduced 0.09%	187,058 Common Stock
Sep 04 2024	SELL Payment of exercise price or tax liability	$14,726 $15.42 p/Share	955 Reduced 0.51%	187,225 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$10,651 $16.8 p/Share	634 Reduced 0.34%	188,180 Common Stock
Jul 15 2024	SELL Open market or private sale	$11,484 $18.0 p/Share	638 Reduced 0.34%	188,814 Common Stock
Jul 12 2024	SELL Open market or private sale	$10,800 $18.0 p/Share	600 Reduced 0.32%	189,452 Common Stock
May 20 2024	SELL Open market or private sale	$146,963 $15.19 p/Share	9,675 Reduced 4.84%	190,052 Common Stock
May 17 2024	SELL Open market or private sale	$125,737 $15.14 p/Share	8,305 Reduced 3.99%	199,727 Common Stock
May 16 2024	SELL Open market or private sale	$15,000 $15.0 p/Share	1,000 Reduced 0.48%	208,032 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$18,481 $12.28 p/Share	1,505 Reduced 0.71%	209,032 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$9,816 $12.9 p/Share	761 Reduced 0.36%	210,537 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	44,100 Added 17.27%	211,298 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$6,492 $14.46 p/Share	449 Reduced 0.27%	167,198 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	-	14,200 Added 7.81%	167,647 Common Stock
Jul 11 2023	SELL Open market or private sale	$267,930 $18.04 p/Share	14,852 Reduced 8.82%	153,447 Common Stock

Natarajan Sethuraman

President, Research & Develop.

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Value

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA

Account